Publication | Open Access

Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response

Anti-tumor ResponseTumor ImmunologyCancer ImmunosurveillanceIntratumoral Dna-based DeliveryMedicineT-regulatory CellImmunologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentCheckpoint-inhibiting Antibodies